scispace - formally typeset
J

Jesús Planagumà

Researcher at Hebron University

Publications -  9
Citations -  402

Jesús Planagumà is an academic researcher from Hebron University. The author has contributed to research in topics: Tumor progression & Cancer. The author has an hindex of 8, co-authored 9 publications receiving 376 citations. Previous affiliations of Jesús Planagumà include Autonomous University of Barcelona & University of Helsinki.

Papers
More filters
Journal ArticleDOI

A Differential Gene Expression Profile Reveals Overexpression of RUNX1/AML1 in Invasive Endometrioid Carcinoma

TL;DR: Tissue array immunohistochemistry showed that RUNX1/AML1 up-regulation correlates to the process of tumorigenesis, from normal atrophic endometrium to simple and complex hyperplasia and then, on to carcinoma.
Journal ArticleDOI

Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells

TL;DR: T-PA, in addition to its known role in invasion, plays other critical roles in pancreas tumor progression, stimulating cancer cell proliferation and tumor-associated angiogenesis.
Journal ArticleDOI

Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma

TL;DR: Results indicate concurrent mechanisms in expression of MMP-2 and -9, RUNX1/AML1 and ETV5/ERM, and several of the basement membrane components, which are likely to associate with the invasive stage of EEC and OEC.
Journal ArticleDOI

Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors.

TL;DR: Genes involved in the mitotic checkpoint as a major mechanism of carcinogenesis in non-endometrioid endometrial cancer, or altered genes associated with the initial steps of myometrial infiltration in endometriatory cancer, represent examples of how useful large genetic screenings can be for understanding the tumorigenesis process and the future directions in the molecular pathogenesis of endometrian cancer.